ClinicalTrials.gg
Active, not recruitingNCT05256940MI-SIUpdated Oct 27, 2026

Motivational Interviewing to Address Suicidal Ideation for Veterans at High Risk for Suicide

An interventional study of Motivational Interviewing to Address Suicidal Ideation- Revised (MI-SI-R) and Enhanced usual care (EUC) in Suicide, Attempted and Suicidal Ideation, sponsored by VA Office of Research and Development. Active, not recruiting at 3 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-27.

Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Treatment

How we know

Updated Oct 27, 2026Primary completion movedEligibility revisedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
368
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 11 studies in Suicide, Attempted by VA Office of Research and Development — 5 open to participants now, 7 under way, none of them phase 3. Suicide, Attempted · VA Office of Research and Development.

Enrollment
3rd of 11
368 · median 156
Started
2022
the only one that year
No phase
9 of 11
4 open now
Registered
6th of 11
by date

Among the 11 studies in Suicide, Attempted by VA Office of Research and Development, this one is the 3rd largest by enrollment, is the only one that started in 2022, is one of 9 with no phase, and was the 6th registered.

Suicide, Attempted

281 studies on the registry are indexed under Suicide, Attempted; 90 are open to participants now.

Browse Suicide, Attempted studies →

Open to participants now

5 of the 11 studies in Suicide, Attempted by VA Office of Research and Development are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Where they have run

Who these studies take

Of the 67 Suicide, Attempted studies recruiting now, 34 (51%) set no upper age limit and 32 (48%) stop at 75 or younger; 28 take children under 18; 11 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 11 studies in Suicide, Attempted by VA Office of Research and Development, or all of them as a file.
02

Study summary

The purpose of this project is to conduct a randomized control trial with 470 Veterans to examine the impact of a revised version of Motivational Interviewing to Address Suicidal Ideation (MI-SI-R) on risk for suicide attempts and suicidal ideation when compared to high quality usual care.

Read the detailed description

Research suggests that treatments to reduce suicidal behavior may need to focus on both the motivation to live and the motivation to die to obtain optimal effects. The PI developed a revised version of Motivational Interviewing to Address Suicidal Ideation (MI-SI-R) to help Veterans resolve ambivalence about living by increasing the motivation to live, that consists of three sessions delivered in-person, virtually, or by telephone. Enhanced usual care (EUC) for high-risk Veterans includes safety plans administered or reviewed by research therapists, care coordination, and access to a 24-hour crisis hotline. In a preliminary randomized controlled trial (RCT) in psychiatrically hospitalized Veterans, MI-SI-R plus EUC was associated with 50% fewer suicide attempts and 41% lower likelihood of suicidal ideation compared to EUC alone. The investigators are proposing an RCT comparing MI-SI-R plus EUC (MI-SI-R+EUC) to EUC alone in a sample of 470 high-risk Veterans with recent suicidal crises from three VHA Medical Centers, with "high-risk" defined as a suicide attempt within a month or suicidal ideation > 5 on the Beck Scale for Suicidal Ideation. Half (n = 235) will be randomized to MI-SI-R+EUC (three sessions in-person, via Video Connect, or telephone) and the remaining participants (n = 235) will receive EUC alone. All participants will be asked to complete telephone follow-up assessments at 1, 3, 6, and 12-months after randomization. This will allow the investigators to determine the efficacy of MI-SI-R+EUC in reducing risk for suicide attempts (Aim 1) and reducing overall suicidal ideation (Aim 2) when compared to EUC alone.

03

Conditions studied

  • Suicide, Attempted
  • Suicidal Ideation

Keywords

  • veterans
  • motivational interviewing
04

Who can participate

The criteria were revised on the registry on Oct 27, 2026. See what changed

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Veteran status
  • admitted to an inpatient unit, referred by a suicide prevention coordinator, or identified as high-risk via data extraction
  • English speaking and reading
  • ability to understand the study and provide
  • high-risk status confirmed by suicide attempt within a month on the Columbia- Suicide Severity Rating Scale or a score > 5 on the Scale for Suicidal Ideation

Exclusion criteria

Exclusion Criteria:

  • current psychosis
  • active mania
  • dementia
  • impaired decision making capacity
  • institutionalization due to hospitalization in a non-VA facility, jail, or prison
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
368 participants (actual)

Study arms

  • Experimental
    Motivational Interviewing to Address Suicidal Ideation- Revised (MI-SI-R)

    Motivational Interviewing to Address Suicidal Ideation (MI-SI-R) was developed to help Veterans resolve ambivalence about living by increasing the motivation to live, and is delivered in three sessions in person, virtually, or by telephone.

    Behavioral: Motivational Interviewing to Address Suicidal Ideation- Revised (MI-SI-R) · Other: Enhanced usual care (EUC)

  • Active comparator
    Enhanced usual care (EUC)

    Enhanced usual care (EUC) includes safety plans administered or reviewed by research therapists, care coordination, and access to a 24-hour crisis hotline.

    Other: Enhanced usual care (EUC)

Interventions

  • BehavioralMotivational Interviewing to Address Suicidal Ideation- Revised (MI-SI-R)

    Motivational Interviewing to Address Suicidal Ideation (MI-SI-R) was developed to help Veterans resolve ambivalence about living by increasing the motivation to live, that is delivered in three sessions in person, virtually, or by telephone.

  • OtherEnhanced usual care (EUC)

    Enhanced usual care (EUC) includes safety plans administered or reviewed by research therapists, care coordination, and access to a 24-hour crisis hotline.

06

What researchers measure

Primary outcomes

  1. Columbia-Suicide Severity Rating Scale

    The first primary outcome is the presence (vs. absence) of non-fatal suicide attempts as reported on the Columbia-Suicide Severity Rating Scale.

    Time frame: 12-months

  2. Beck Scale for Suicidal Ideation

    The second primary outcome is suicidal ideation as reported on the Beck Scale for Suicidal Ideation, which has a range from 0-38, with higher scores indicating more severe suicidal ideation.

    Time frame: 12-month

07

Study locations

3 sites
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — Members of the scientific community who would like a copy of limited data sets (i.e., data sets underlying any publication) from this study can request a copy by e-mailing the PI at Peter.Britton@va.gov. They should state their reason for requesting the data, their plans for analyzing the data, and agree not to attempt to re-identify participants. Limited data sets will be encrypted uploaded to a protected share-point; and the password will be sent to the requestor via a separate e-mail.

Supporting information: Clinical study report

Time frame: Limited data sets will be available per a Data Use Agreement (DUA), which will determine the time frame.

Access criteria: Limited data will be provided after requestors sign a Data Use Agreement (DUA).

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2022 (actual). Primary completion is estimated for Jun 2027, 54 months after the start.

Of 145 non-industry interventional studies with no phase under Suicide, Attempted, half reached primary completion within 38 months of starting (the median), counting those still running; a quarter within 21 and three quarters within 56. This study's planned 54 months is above that.

Counting every sponsor, half of 147 studies reached it within 37 months; a quarter within 20 and three quarters within 56.

Primary completion moved once since we started tracking on Sep 25, 2026: Mar 2026 → Jun 2027, on Oct 27, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Feb 16, 2022
First posted
Feb 25, 2022
StartActual
Nov 30, 2022
Primary completionEst.
Jun 29, 2027was Mar 2026
CompletionEst.
Jun 29, 2027
Last update
Oct 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Mar 31, 2026→Jun 29, 2027
Oct 27, 2026
Eligibility
1 inclusion criterion edited, 1 removed; 1 exclusion criterion edited
What changed in the criteria
Inclusion criteria
  • Removedage 18 and over,
  • EditedEnglish speaking and reading, and
Exclusion criteria
  • Editedimpaired decision making capacity, and
Oct 27, 2026
Show all 1 update
  1. Oct 27, 2026
    Primary completion Mar 31, 2026→Jun 29, 2027
    Eligibility 1 inclusion criterion edited, 1 removed; 1 exclusion criterion edited
    What changed in the criteria
    Inclusion criteria
    • Removedage 18 and over,
    • EditedEnglish speaking and reading, and
    Exclusion criteria
    • Editedimpaired decision making capacity, and
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05256940
Collaborators
Syracuse VA Medical Center, Portland VA Medical Center, Ralph H. Johnson VA Medical Center
Responsible party
Sponsor
First posted
Feb 25, 2022
Start date
Nov 30, 2022
Primary completion
Jun 29, 2027 (estimated)
Completion
Jun 29, 2027 (estimated)
Last update
Oct 27, 2026

Study contacts

Peter C. Britton, PhD MS
principal investigator · VA Finger Lakes Healthcare System, Canandaigua, NY

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion